Reports/OTCMKTS:HGRAF
OTCMKTS:HGRAF

OTCMKTS:HGRAF - HydroGraph Clean Power Inc

AVOID [CAP] SPECULATIVE BUY?AVOIDREDUCE ZONEBasic Materials - Chemicals - Specialty2026-08-14Data 29 days oldUSD 4.50
29
Conviction
out of 100

Executive Summary

HydroGraph Clean Power Inc (HGRAF) is a Canada-based speciality chemicals company focused on the production of high-purity graphene using a patented detonation process. The company positions itself as an early-stage commercial supplier of graphene materials targeting industrial, electronics, energy storage, and composite applications, though it remains a small player in a fragmented and largely pre-commercial graphene market.

The investment case rests on the company's ability to convert its new Austin, Texas headquarters and expanded production footprint into recurring commercial revenue, with the next earnings release (scheduled for 3 June 2026 per public listings data) serving as the key near-term window to demonstrate order traction. The primary risk is that continued operating losses force further capital raises, diluting existing shareholders before the commercial story is established.

SPECULATIVE BUY. Conviction Score: 49/100. The view would shift to a higher conviction on evidence of named, multi-customer commercial contracts translating into a measurable revenue step-change, and would downgrade on a confirmed dilutive financing or a missed commercial milestone at the next reporting date.

AVOID at 29/100. Not currently actionable.
REDUCE ZONEAVOID · 29/100

Business Model

HydroGraph generates revenue from the sale of graphene and graphene-related materials produced via its proprietary detonation synthesis process, which the company states yields high-purity, low-defect graphene at scale. The addressable customer base spans industrial composites, lubricants, energy storage (batteries and supercapacitors), electronics, and academic and research institutions, with the company historically selling in small volumes to a mix of these end-markets.

At present, revenue is modest - historical reporting referenced approximately USD43,051 in a recent period, reflecting very early-stage commercialisation rather than a scaled product business. Margins, pricing, and revenue mix are not disclosed at a granularity that allows for segment-level analysis, and the business continues to operate at a loss, with earnings power well below the level required to justify the current market capitalisation on a fundamental basis. The competitive moat, if any, rests on the patented production process and what the company describes as a higher purity and lower defect profile versus alternative graphene grades, but this technical differentiation has not yet been validated by sustained, large-scale customer adoption.

The company's go-to-market model relies on a combination of direct sales, distribution partnerships, and joint development agreements with downstream users. Commercial traction to date is limited, and the business model is therefore best characterised as pre-revenue to early-revenue, with the investment proposition hinging on the speed at which production capacity (anchored by the new Austin facility) is converted into paid orders.

Financial Snapshot

Price
USD 4.50
Market Cap
USD 1.8bn
52w High
USD 8.37
52w Low
USD 1.00
Distance from 52wH
-46.2%
Beta
0.86
Avg Volume
1161914
Currency
USD

Recent Catalysts

[April 2026] - HydroGraph announced the opening of its new Austin, Texas headquarters, expanding its operational footprint and positioning the company closer to US customers and partners. The release noted the listing on OTCQB under the symbol HGRAF alongside the CSE listing. Source: GlobeNewswire company press release (14 April 2026).

[April 2026] - Public listings data indicated that HydroGraph's next earnings report date is scheduled for 3 June 2026, which is the next confirmed window for disclosure of revenue traction and order pipeline progress. Source: TipRanks public earnings calendar.

[2026 YTD] - Equity research commentary published on Seeking Alpha characterised HydroGraph as a leader in graphene development but explicitly flagged it as a speculative play with scant revenue, suggesting 2026 is positioned as a pivotal year for commercial validation. Source: Seeking Alpha published article (aggregator commentary; underlying company claims not independently verified).

[April 2026] - Yahoo Finance quote pages for HGRAF (OTCMKTS) and HG.CN (CSE) showed trading data through 23 - 24 April 2026, confirming continued dual-listing liquidity and that the OTCMKTS price reference point of USD4.5 reflects the prevailing quotation used in this report. Source: Yahoo Finance public market data pages.

Thesis Evaluation

Bull Case (16% weight)

HydroGraph converts the new Austin facility into paid commercial orders from multiple named customers, revenue steps up from current nominal levels (circa USD43,051) into the low single-digit millions of USD, and the market re-rates the stock towards a pre-commercial graphene peer multiple. Price target of 8.00 over a 12-month horizon, broadly anchoring to the 52-week high of USD8.37 and reflecting the upper bound of where speculative capital has previously valued the equity.

Base Case (48% weight)

Revenue grows modestly from current nominal levels but the company remains loss-making, with periodic small capital raises to fund operations. The stock continues to trade on sentiment and technicals rather than fundamentals, oscillating around current levels. Price target of 3.20 over a 12-month horizon, reflecting modest mean-reversion below the current USD4.5 quotation as the initial momentum trade fades absent hard catalysts.

Bear Case (36% weight)

The company fails to secure meaningful commercial contracts, losses continue to erode the capital base, and a further dilutive financing is required at a lower share price, compounding shareholder dilution. Price target of 1.10 over a 12-month horizon, broadly anchoring to the 52-week low of USD1.00 and reflecting the practical floor if cash runway becomes a concern.

Weighted conviction:Bull (16%) x 100 + Base (48%) x 62 + Bear (36%) x 10 = 29/100. AVOID.

Key Risks

  1. Dilution from ongoing capital raises: Sustained operating losses are likely to require additional equity issuance, which would dilute existing holders and weigh on the share price. Estimated probability: 70%. Impact: severe.
  2. Absence of commercial revenue traction: Revenue remains at nominal levels (circa USD43,051 in recent reporting) with no clear visibility on a step-change in customer orders, undermining the investment case. Estimated probability: 55%. Impact: severe.
  3. Negative earnings and weak price momentum: The company is unprofitable with a negative P/E, and price momentum has been soft, leaving the share price vulnerable to further re-rating lower. Estimated probability: 60%. Impact: moderate.
  4. Limited operational track record: As an early-stage commercial supplier, HydroGraph has minimal operating history at scale, increasing execution risk on production, quality, and customer delivery. Estimated probability: 50%. Impact: moderate.
  5. Sector and liquidity risk: The graphene market is fragmented and largely pre-commercial, and HGRAF trades on OTCMKTS with limited liquidity, which can amplify price swings in both directions. Estimated probability: 65%. Impact: moderate.

Who Should Own It / Avoid It

Ideal for: Speculative, high-risk-tolerant investors with a minimum holding period of 12 - 24 months who are comfortable with pre-revenue, loss-making equities and who can tolerate meaningful drawdowns. The position should be sized as a small satellite allocation within a diversified portfolio, with the investor accepting that the thesis depends on commercial execution rather than current cash flows.

Avoid if: You require positive earnings, established revenue, or a clear path to profitability before investing, or if you cannot tolerate the realistic prospect of a 50%+ drawdown from current levels. Investors with a short time horizon, low risk tolerance, or a mandate restricted to profitable, dividend-paying issuers should not hold this name.

Recommendation

SPECULATIVE BUY - 49/100. The call reflects a balanced view where modest upside from a successful commercial pivot is roughly offset by the elevated risk of further dilution and sub-scale revenue, keeping conviction below the 50 mark. The view would upgrade to a higher tier on confirmation of multi-customer revenue traction and a clear path to operating cash flow break-even, and would downgrade on a confirmed dilutive raise at a discount to market, a missed commercial milestone, or a sustained move below the 52-week low of USD1.00. At the current price of $4.50 the shares trade at or above our base-case target of $3.20: the base case is fully priced, existing holders should consider trimming, and new positions are not advised above $1.80.

The probability-weighted value across our three scenarios is $3.21, 29% below the current price of $4.50 - the market is currently pricing the shares ahead of our probability-weighted view. Levels below are derived from the scenario targets and probabilities above, not from percentage offsets to today's price.

BUY

below $1.80 - below this level the upside to the base-case target ($3.20) is at least 2x the downside to the bear case ($1.10), the minimum risk/reward we require before committing new capital.

HOLD

between $1.80 and $3.20 - the base case is not yet fully priced, so existing holders are paid to wait, but new money gets no margin of safety in this zone.

REDUCE

above $3.20 - at this level the base case is fully reflected in the price and anything beyond it is paying for a bull scenario we weight at 16%.

SELL

if the investment thesis would be invalidated by a confirmed dilutive equity raise at a meaningful discount to market combined with no measurable revenue step-change at the next reporting date, or by the loss of a named commercial customer or partner that materially undermines the production scaling plan, regardless of price - the bear target of $1.10 is the backstop, not an arbitrary percentage stop.

Conviction Trend

Latest conviction: 29/100. Trend versus prior report: Flat.

CONVBUYOPPSPECAVOID1007550250Conviction (0-100)2026-04-282026-05-302026-06-282026-07-252026-08-14
CONVICTION BUY (80+)BUY (65 - 79)OPP BUY (50 - 64)SPEC BUY (30 - 49)AVOID (0 - 29)
Report dateConviction
2026-08-1429
2026-07-2529
2026-06-2829
2026-05-3059
2026-04-2873

Sources

Market data: DYOR HQ proprietary market data workflow.

Public sentiment and news flow: Public news flow from company press releases on GlobeNewswire, public market data pages on Yahoo Finance, earnings calendar disclosures from TipRanks, and aggregator commentary on Seeking Alpha were reviewed for context on price action, corporate announcements, and the broader narrative around the stock.

Primary source types: Company press releases (GlobeNewswire), public market data and quote pages (Yahoo Finance, StockAnalysis.com), public earnings calendar listings (TipRanks), and aggregator-published equity research (Seeking Alpha) were the source categories drawn upon for this report.

Key sources

Data correct as of 2026-08-14